Despite the disruption caused by Covid-19, the European ‘SWEETWOODS’ wood-to-bio-based products project is progressing well, according to the partners involved in the initiative.
The project is led by Estonia-based Graanul Biotech and involves nine European companies.
The main key aim of the initiative is to develop a first-of-its-kind biofractionation flagship plant in Estonia to turn sustainable hardwood residues into high-purity intermediate building blocks of cellulosic sugars and high-quality lignin, which can then be turned into bio-based chemicals or bioplastics.
According to the organisers of the project, its consortium had a productive review meeting in Brussels at the beginning of March where external experts took a closer look at its progress and confirmed that SWEETWOODS project “was on track”.
The Bio-based Industries Joint Undertaking (BBI JU) has funded the SWEETWOODS project. According to the consortium, the SWEETWOODS project periodic report for the first 18 months was accepted by the BBI JU.
In a statement, the consortium said: “As of today, SWEETWOODS flagship plant construction works have been finished and key equipment installation is nearly completed.
Although due to COVID-19 pandemics delivery of certain equipment and instruments have been delayed, nevertheless all preparations are in place to start with commissioning as soon as pandemic related restrictions allow.”
If you were interested in this story, you may also be interested in the ones below.